Software Engineering Contractor

Board of Directors

Proven leadership guides Centice Corporation’s pursuit of innovative products and services

At all levels of our organization, Centice Corporation relies on driven, forward-thinking individuals to define our direction. Discover More… about the leaders who help us realize our vision and achieve success.

Scott Albert

Chairman of the Board
Managing General Partner, The Aurora Funds, Inc.

Scott Albert co-founded The Aurora Funds with Jeff Clark in 1994, after already spending nearly a decade in the venture capital industry. Having also spent time as an entrepreneur, he wanted to create an entrepreneurs-friendly venture capital firm that could offer hands-on support and guidance, in addition to funding. Today, he leads the IT investment team at Aurora and also oversees much of the day-to-day management of the firm. Prior to forming The Aurora Funds, Scott was the Chief Investment Officer of the North Carolina Technological Development Authority, Inc. (“NCTDA”), a state-funded corporation that supports technology-based entrepreneurial companies in North Carolina. While there, he led the new venture investment efforts and performed portfolio company monitoring for the NCTDA’s extensive statewide portfolio. Prior to serving at the NCTDA, he was at Criterion Venture Partners in Houston, Texas, as a General Partner for a $30 million pool of capital, and with Golder, Thoma and Cressey, in Chicago. In addition, he has served as President of a venture-backed start-up company. Before entering the venture capital industry, he was a consultant for Booz, Allen and Hamilton. During his venture capital career, Scott has helped close more than 40 investment deals, including a broad range of Information Technology and Life Science companies. Scott currently serves on the boards of several Aurora portfolio companies, including ALN Medical Management, Centice, StrikeIron and TriVirix. Scott was previously on the boards of Solution Technology (acquired by Rodel) and DataFlux (acquired by SAS) and led the investment in Blackboard (NASDAQ: BBBB). Scott has a bachelor’s of science in Engineering from Duke University and a MBA from the University of Chicago.

Tom Scholl

General Partner, Novak Biddle Venture Partners

Tom is a successful entrepreneur and investor with experience sitting on both sides of the boardroom table. He has over twenty-five years experience in communications systems, equipment, chipsets and software, and has been active in the high-tech start-up scene in the Washington metro area for over 15 years.

He currently sits on the boards of Novak Biddle portfolio companies Centice, Paratek, Princeton Optronics, Command Information, Fiberzone Networks, Digital Bridge and Avail Media.

In 1990, Tom founded Telogy Networks, a leader in providing embedded communications software products for wireless and IP networks. Telogy’s award-winning products were proven market successes with world-class customers such as Cisco, Motorola, Samsung, Nortel, Alcatel and NEC. In 1998, Motorola purchased Telogy’s digital cellular technology and development team for over $40M, and in 1999, Texas Instruments purchased Telogy as the leader in embedded VOIP software for over $700M.

Prior to joining Novak Biddle, Tom co-founded and was chairman of Cognio, a developer of spectrum management and MIMO antenna technology for wireless applications. Cognio was acquired by Cisco in October 2007. Tom has also served as a Director of Torrent Networking, acquired by Ericsson, and Integrated Telecom, acquired by PMC Sierra.

In 1995, Tom was recognized as the Joseph A. Sciulli “Entrepreneur of the Year” by the Maryland High Technology Council. Prior to Telogy, Tom was Senior Vice President of Engineering at Hughes Network Systems, a combination of M/A-Com DCC and Linkabit.

Tom is a member of the Board of Trustees at the University of Maryland and Chairman of the Board of Visitors at the Clark School of Engineering. He is also a member of the Dean’s Advisory Council of the College of Liberal Arts at Purdue University.

Tom has patents relating to software, the Internet, and digital telephone systems, and he is the author of “Packet Switching” in McGraw Hill’s Electronic Communications Handbook. He’s a member of IEEE and ACM, and he is an alumnus of Purdue University and the Executive Management (non-degree) program at MIT Sloan School.

Aidar Gabidullin

Oscriva LtdBio

Aidar Gabidoullin is a Partner of S-Group Capital Management, with responsibility for financial and high-growth technology companies. He has extensive experience both in acquisitions and in strategic and operational management of high-growth companies in the financial and high-tech industries.

Prior to joining S-Group Capital Management, Aidar worked for Andersen Consulting in London, McKinsey & Co. in Russia and Capital One in the United States. Aidar is on the board of directors of five companies located in Russia, the US and Europe.

Mr. Gabidoullin graduated from the Moscow Institute of Physics and Technology and holds an MBA degree from the INSEAD Business School (France).

David Brady, PhD

Chief Scientist and Co-Founder, Centice Corporation

David Brady holds a B.A. in physics and mathematics from Macalester College and M.S. and Ph D degrees in applied physics from the California Institute of Technology. He was on the faculty of electrical and computer engineering at the University of Illinois in Urbana-Champaign from 1990 until joining the Duke faculty as founding director of the Fitzpatrick Institute for Photonics in 2001. Professor Brady leads the Duke Imaging and Spectroscopy Program (www.disp.duke.edu), which builds computational optical sensors for hyperspectral imaging, 3-D microscopy, molecular imaging and chemometrics and wide field cameras. Dr. Brady is the author of Optical Imaging and Spectroscopy (OSA-Wiley 2009) and is a fellow of the Optical Society of America, SPIE and IEEE.

Discover More… about Centice Corporation

Executive Team

Proven leadership guides Centice Corporation’s pursuit of innovative products and services

At all levels of our organization, Centice Corporation relies on driven, forward-thinking individuals to define our direction. Discover More… about the leaders who help us realize our vision and achieve success.

Scott Albert

Chairman of the Board and Chief Executive Officer
Managing General Partner, The Aurora Funds, Inc.

Scott Albert was appointed President and CEO in June of 2009, having been a lead investor of Centice and serving on the company’s Board of Directors since its founding in the summer of 2004. Mr. Albert brings a unique combination of executive, operational, investment and financial experience to Centice, having worked with over fifty venture backed companies in the technology and medical areas throughout his career.

Mr. Albert co-founded The Aurora Funds, Inc., a lead investor in Centice, in 1994, after already spending nearly a decade in the venture capital industry. Today, he leads the IT investment team at Aurora and also oversees much of the day-to-day management of the firm. Prior to forming The Aurora Funds, he was the Chief Investment Officer of the North Carolina Technological Development Authority, Inc. (“NCTDA”), a state-funded corporation that supports technology-based entrepreneurial companies in North Carolina. While there, he led the new venture investment efforts and performed monitoring for the NCTDA’s extensive statewide portfolio. Prior to serving at the NCTDA, he was at Criterion Venture Partners in Houston, Texas, as a General Partner for a $30 million pool of capital, and with Golder, Thoma and Cressey, in Chicago. In addition, he served as President of a venture-backed start-up company in Houston, Texas. Before entering the venture capital industry, he was a consultant for Booz, Allen and Hamilton. Mr. Albert currently serves on the boards of several other Aurora portfolio companies, including ALN Medical Management, StrikeIron, TriVirix and Unitrends. He was previously on the boards of Solution Technology (acquired by Rodel) and DataFlux (acquired by SAS) and led Aurora’s investment in Blackboard (NASDAQ: BBBB). Mr. Albert has a bachelor’s of science in Engineering from Duke University and an MBA from the University of Chicago.

Prasant Potuluri, Ph. D.

Chief Technology Officer

Dr. Prasant Potuluri is the Chief Technology Officer at Centice Corporation, primarily focusing on identifying and evaluating new technology and providing strategic vision and direction to the engineering group. He has pursued several federal grants for Centice and has won close to $1.4 million in research funds. He also strategically manages the Intellectual portfolio of the company.

Prior to co-founding Centice in 2004, Prasant was a graduate research assistant at Duke University and developed the company’s core computational sensor technology platform. His PhD thesis, “Multiplexed Optical Sensors for Reference Structure Tomography and Compressive Spectroscopy”, was the first demonstration of compressive sampling, a revolutionary concept. In 2004, Prasant was awarded the John T. Chambers Fellow for demonstrating excellence in classroom activities, research activities and for participation in Duke Activities. Prasant played a critical role in winning the grand prize at the Duke Startup Challenge.

Dr. Potuluri obtained a PhD from Duke University, a master’s degree from University of Illinois at Urbana-Champaign and a bachelor’s degree in Technology from the Indian Institute of Technology, Bombay. He is a member of the Optical Society of America, SPIE and Sigma-Xi. He founded the Duke Chapter of the Optical Society of America and held the office of the President for the chapter during 2003-2004.

Discover More… about Centice Corporation

Careers

Help shape the pharmaceutical safety industry by embarking on a career with us

Centice Corporation helps people do amazing things – and we want to enable our employees to do amazing things too. We are a dynamic, fast-paced organization providing an environment of individual responsibility with a problem-solving focus.

We are seeking individuals who embrace the challenge of bringing innovative products to market and building a dynamic and enduring company. Centice looks for talent who exude excellence and enthusiasm to adjoin their valuable expertise to our high quality team.

Discover More… professional opportunities at Centice Corporation

Current Openings:

  • We currently do not have any positions available at this time, please check back with us soon.

Apply Online

To apply, please paste your resume in the message field of your e-mail. In the subject line of the e-mail, please include your name and the position you are applying for. Apply Now.

Benefits Provided

In addition to a dynamic work environment, we also offer a competitive compensation and benefits package. Click here for more information.

What our employees have to say

“I joined Centice because the cutting edge technologies that Centice has been creating to improve the quality and efficiency of dispensed medications strongly appealed to me. The success and reputation of Centice drove me to dedicate my knowledge and experience to the company – I feel privileged to have the opportunity to work for Centice. Furthermore, I am excited to work with such enthusiastic, collaborative, and high-energy teams, which was another important factor in deciding to join Centice – to achieve common goals and accomplish my dreams.”
Yuting Qi, PhD, Research Scientist

Discover More… about Centice Corporation

Investors

A strong group of forward-thinking investors help propel Centice into the future

Centice Corporation’s efforts to bring cutting-edge optical sensor technology to the pharmaceutical market have been backed by venture capital investments from a number of notable firms. Discover more… about our investors.

THE AURORA FUNDS

Founded in 1994, The Aurora Funds is a venture capital firm that provides capital, connections and strategic guidance to entrepreneurs with early-stage health care, life sciences and information technology companies in the southeastern and mid-Atlantic United States. The firm manages more than $230 million in five venture funds. For more information, visit www.aurorafunds.com.

NOVAK BIDDLE VENTURE PARTNERS

Novak Biddle Venture Partners is a leading early-stage venture capital firm focused on unique, cutting-edge technology investments in the eastern United States, as well as targeted opportunities nationwide. With $580 million under management, Novak Biddle operates five venture funds that currently provide equity financing and management assistance to 42 portfolio companies. Novak Biddle continues to seek business situations where the combination of ideas, dollars, experience and relationships can create long-term, sustainable value. For more information, visit www.novakbiddle.com.

S-GROUP DIRECT INVESTMENTS LTD.

Founded in 2006, S-Group Direct Investments Ltd. is a private equity and venture capital firm currently investing out of its first fund with $250 million committed. S-Group is focused on companies within a broad range of industries, which includes technology, chemistry, engineering, financial services, and retail/consumer goods, located in Russia, the U.S., and Europe.

INNOVATION VENTURES, L.P.

Innovation Ventures is a licensed SBIC venture capital fund focused on investment opportunities in emerging technology businesses. Innovation Ventures, L.P., was formed by a team of seasoned venture managers and investors associated with the Delaware Innovation Fund, which has an eight-year history of successfully investing in and working with leading-edge technology entities throughout the mid-Atlantic region. For more information, visit www.innovationventures.com.

FULCRUM FINANCIAL GROUP

Fulcrum Financial Group provides customized asset management services to institutional investors and high net worth individuals. Founded in 2000, Fulcrum investments range from publicly traded securities, to structured and derivative contracts, to venture investments. Fulcrum’s venture investments focus on early stage companies based in central North Carolina.

Discover More… about Centice Corporation

Our Business Partners

Discover More… about our mutually beneficial industry partnerships

Centice Corporation recognizes that collaboration is essential to developing, marketing and bringing new technology to the market. Centice has worked hard to cultivate relationships with like-minded, innovative companies with the belief that the patient will benefit in the long run.

Medi-Span


Medi-Span® is the leading provider of drug information for thousands of health care professionals worldwide. With more than 30 years experience, Medi-Span continues to offer authoritative drug databases in a variety of formats, including clinical decision support and disease suite modules, application programming interfaces and stand-alone software applications. In conjunction with superior implementation and experienced customer support, the Medi-Span product line is the perfect choice for those needing accurate, trusted, drug data that easily integrates into existing software applications. For more information, visit www.MediSpan.com.

Medi-Span is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. Wolters Kluwer Health is a division of Wolters Kluwer, Wolters Kluwer Health is a division of Wolters Kluwer, a leading global information services and publishing company with annual revenues (2007) of €3.4 billion ($4.8 billion), maintains operations in over 33 countries across Europe, North America, and Asia Pacific and employs approximately 19,500 people worldwide. Visit www.wolterskluwer.com for information about our market positions, customers, brands, and organization.


NC Mutual Wholesale Drug Company

In 1952, Mutual Drug was formed by independent pharmacists. The company’s goal then, and now, is to provide services needed to ensure member stores’ success. Their commitment to this success includes providing equal pricing, regardless of volume, as well as programs and services designed for the needs of an independent pharmacy. For more information, please visit www.mutualdrug.com.


VisionPoint Marketing

VisionPoint Marketing is a marketing solutions agency providing integrated programs – interactive and/or traditional tactics – for mid-sized organizations in a variety of industries including higher education, healthcare, biotech/life sciences, pharmaceutical, high tech, and business services. For more information, please visit www.visionpointmarketing.com.


Discover More… about Centice Corporation

About Us

Discover More… about Centice Corporation’s history and background

In 2004, Centice was founded to commercialize patented and patent-pending computational sensor technology originally developed at Duke University.

Although our technology has multiple applications, Centice has focused on the development of the PASS Rx system – a pharmaceutical verification product. The PASS Rx system improves the verification process for dispensed medications, thereby increasing patient safety, reducing human error and streamlining the pharmaceutical dispensing process.

Our unique sensor technologies impact the health care industry by increasing efficiency, optimizing workflow, providing peace of mind to healthcare providers and boosting patient confidence.

  Download a Corporate Overview

Discover More… about Centice Corporation